Christopher J. Patriquin

2.0k total citations · 1 hit paper
61 papers, 958 citations indexed

About

Christopher J. Patriquin is a scholar working on Immunology, Nephrology and Genetics. According to data from OpenAlex, Christopher J. Patriquin has authored 61 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 27 papers in Nephrology and 24 papers in Genetics. Recurrent topics in Christopher J. Patriquin's work include Complement system in diseases (45 papers), Renal Diseases and Glomerulopathies (27 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). Christopher J. Patriquin is often cited by papers focused on Complement system in diseases (45 papers), Renal Diseases and Glomerulopathies (27 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). Christopher J. Patriquin collaborates with scholars based in Canada, United States and United Kingdom. Christopher J. Patriquin's co-authors include Donald M. Arnold, Ishac Nazy, Kevin H.M. Kuo, Laura Connelly‐Smith, Oluwatoyosi A. Onwuemene, Austin Kulasekararaj, Hubert Schrezenmeier, Régis Peffault de Latour, Caroline R. Alquist and Nicole A. Aqui and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Christopher J. Patriquin

52 papers receiving 945 citations

Hit Papers

Guidelines on the Use of Therapeutic Apheresis in Clinica... 2023 2026 2024 2025 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
    2023 199 citations Christopher J. Patriquin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Patriquin Canada 13 600 348 303 270 93 61 958
Bérangère S. Joly France 15 797 1.3× 373 1.1× 530 1.7× 323 1.2× 64 0.7× 62 1.1k
B. Brenner Israel 11 1.2k 1.9× 648 1.9× 1.0k 3.4× 381 1.4× 102 1.1× 21 1.7k
Kenneth V. Lieberman United States 15 255 0.4× 485 1.4× 103 0.3× 98 0.4× 117 1.3× 38 989
Antonella Trivelli Italy 17 381 0.6× 773 2.2× 126 0.4× 99 0.4× 201 2.2× 38 1.3k
Enrico Minetti Italy 14 327 0.5× 301 0.9× 102 0.3× 44 0.2× 210 2.3× 35 851
Christelle Barbet France 12 268 0.4× 293 0.8× 86 0.3× 47 0.2× 90 1.0× 39 622
Joseph H. Troll United States 10 950 1.6× 414 1.2× 1.0k 3.4× 276 1.0× 236 2.5× 11 1.6k
A Lattuada Italy 20 551 0.9× 216 0.6× 919 3.0× 265 1.0× 280 3.0× 46 1.6k
S.J. Machin United Kingdom 14 195 0.3× 104 0.3× 330 1.1× 81 0.3× 100 1.1× 24 920
Alberto Magnasco Italy 15 181 0.3× 633 1.8× 116 0.4× 154 0.6× 247 2.7× 37 1.1k

Countries citing papers authored by Christopher J. Patriquin

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Patriquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Patriquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Patriquin more than expected).

Fields of papers citing papers by Christopher J. Patriquin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Patriquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Patriquin. The network helps show where Christopher J. Patriquin may publish in the future.

Co-authorship network of co-authors of Christopher J. Patriquin

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Patriquin. A scholar is included among the top collaborators of Christopher J. Patriquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Patriquin. Christopher J. Patriquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chin‐Yee, Benjamin, Benjamin D. Hedley, Rui Su, et al.. (2025). Maternal and fetal pharmacokinetics (PK) of pegcetacoplan in paroxysmal nocturnal hemoglobinuria (PNH): A case report of use in pregnancy. Blood. 146(Supplement 1). 3199–3199.
2.
Piatek, Caroline, Jong Wook Lee, Morag Griffin, et al.. (2024). Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial. Blood. 144(Supplement 1). 2692–2692. 1 indexed citations
3.
Kulasekararaj, Austin, Morag Griffin, Caroline Piatek, et al.. (2024). Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH. Blood. 145(8). 811–822. 2 indexed citations
4.
Patriquin, Christopher J., Andrija Bogdanović, Morag Griffin, et al.. (2024). Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study. Advances in Therapy. 41(5). 2050–2069. 8 indexed citations
5.
Panse, Jens, Koo Wilson, Jesse Fishman, et al.. (2023). Fatigue and health‐related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data. European Journal Of Haematology. 111(1). 72–83. 4 indexed citations
6.
Patriquin, Christopher J., Katerina Pavenski, Michael T. Jurkiewicz, et al.. (2023). Cognitive decline in thrombotic thrombocytopenic purpura survivors: The role of white matter health as assessed by MRI. British Journal of Haematology. 204(3). 1005–1016. 5 indexed citations
7.
Höchsmann, Britta, Régis Peffault de Latour, A. Bradford Hill, et al.. (2023). Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry. Annals of Hematology. 102(11). 2979–2988. 9 indexed citations
8.
Novitzky‐Basso, Igor, Christopher J. Patriquin, Ivan Pašić, et al.. (2023). Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD. Transplantation and Cellular Therapy. 29(12). 773.e1–773.e10. 3 indexed citations
9.
Patriquin, Christopher J., et al.. (2023). Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations. Journal of Blood Medicine. Volume 14. 613–628. 16 indexed citations
10.
Patriquin, Christopher J., et al.. (2023). Predictors of relapse and prophylactic management of immune thrombotic thrombocytopenic purpura. Transfusion and Apheresis Science. 62(4). 103749–103749.
11.
Martinu, Tereza, Christopher J. Patriquin, David Barth, et al.. (2023). Impact of intraoperative therapeutic plasma exchange on bleeding in lung transplantation. The Journal of Heart and Lung Transplantation. 43(3). 414–419. 2 indexed citations
12.
Kulasekararaj, Austin, Robert A. Brodsky, Jun‐ichi Nishimura, Christopher J. Patriquin, & Hubert Schrezenmeier. (2022). The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria. Therapeutic Advances in Hematology. 13. 1554008806–1554008806. 16 indexed citations
13.
Aversa, Meghan, Tereza Martinu, Christopher J. Patriquin, et al.. (2021). Long-term outcomes of sensitized lung transplant recipients after peri-operative desensitization. American Journal of Transplantation. 21(10). 3444–3448. 17 indexed citations
14.
Li, Amanda, Katerina Pavenski, Kevin H.M. Kuo, & Christopher J. Patriquin. (2020). Apheresis education in Canadian residency programs: A needs assessment. Transfusion and Apheresis Science. 59(4). 102780–102780. 2 indexed citations
15.
Gallop, Katy, Shehzad Ali, J. Rafael Sierra, et al.. (2020). PRO32 PREFERENCE WEIGHTS FOR QUALITY-ADJUSTED LIFE-YEARS ESTIMATION FOR TREATMENTS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN FIVE COUNTRIES. Value in Health. 23. S334–S334. 1 indexed citations
16.
Patriquin, Christopher J., Mari Thomas, Tina Dutt, et al.. (2016). Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura. British Journal of Haematology. 173(5). 779–785. 60 indexed citations
17.
Arnold, Donald M., Christopher J. Patriquin, & Ishac Nazy. (2016). Thrombotic microangiopathies: a general approach to diagnosis and management. Canadian Medical Association Journal. 189(4). E153–E159. 86 indexed citations
18.
Kelly, Richard J., Britta Höchsmann, Jeff Szer, et al.. (2015). Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria. New England Journal of Medicine. 373(11). 1032–1039. 195 indexed citations
19.
Kelly, Richard J., Britta Höchsmann, Austin Kulasekararaj, et al.. (2014). Eculizumab Treatment Improves Outcomes of Pregnancy in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 124(21). 4393–4393. 1 indexed citations
20.
Patriquin, Christopher J. & Mark Crowther. (2011). Treatment of warfarin-associated coagulopathy with vitamin K. Expert Review of Hematology. 4(6). 657–667. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bérangère S. Joly Breakdown of academic impact, for papers by B. Brenner Breakdown of academic impact, for papers by Kenneth V. Lieberman Breakdown of academic impact, for papers by Antonella Trivelli Breakdown of academic impact, for papers by Enrico Minetti Breakdown of academic impact, for papers by Christelle Barbet Breakdown of academic impact, for papers by Joseph H. Troll Breakdown of academic impact, for papers by A Lattuada Breakdown of academic impact, for papers by S.J. Machin Breakdown of academic impact, for papers by Alberto Magnasco
Rankless by CCL
2026